highli
pathogen
human
coronavirus
associ
sever
respiratori
syndrom
includ
middl
east
respiratori
syndrom
coronaviru
merscov
recent
emerg
merscov
epidem
start
still
ongo
mortal
rate
approxim
vaccin
avail
merscov
therapeut
option
merscov
infect
limit
palli
support
care
search
specif
antivir
treatment
urgent
need
coronavirus
envelop
virus
spike
protein
present
surfac
respons
viru
entri
target
cell
lectin
attract
anticoronaviru
candid
highli
glycosyl
natur
spike
protein
test
antivir
effect
griffithsin
grft
lectin
isol
red
marin
alga
griffithsia
sp
merscov
infect
result
demonstr
display
signific
cytotox
griffithsin
potent
inhibitor
merscov
infect
griffithsin
also
inhibit
entri
host
cell
particl
pseudotyp
merscov
spike
protein
suggest
griffithsin
inhibit
spike
protein
function
entri
spike
protein
dual
function
entri
mediat
bind
host
cell
surfac
also
fusion
viral
envelop
host
cell
membran
time
cours
experi
show
griffithsin
inhibit
merscov
infect
bind
step
conclus
identifi
griffithsin
potent
inhibitor
merscov
infect
entri
step
coronavirus
belong
coronavirida
famili
envelop
virus
larg
singl
strand
positivesens
rna
genom
infect
human
anim
human
coronavirus
respons
mild
respiratori
diseas
mainli
common
cold
chang
emerg
highli
pathogen
coronaviru
associ
sever
respiratori
syndrom
name
sever
acut
respiratori
syndrom
coronaviru
sarscov
new
deadli
human
coronaviru
emerg
arabian
peninsula
middl
east
respiratori
syndrom
coronaviru
merscov
respons
sever
pneumonia
associ
addit
clinic
symptom
vomit
diarrhea
renal
failur
alhogbani
zaki
et
al
merscov
epidem
still
ongo
far
laboratoryconfirm
case
diagnos
mortal
rate
approxim
neither
clinic
approv
antivir
vaccin
avail
merscov
therapeut
option
merscov
infect
limit
palli
support
care
merscov
spike
protein
main
determin
viru
entri
host
cell
mediat
bind
dipeptidyl
peptidas
receptor
fusion
viral
envelop
host
cell
membran
millet
whittak
raj
et
al
type
fusion
protein
highli
glycosyl
predict
nglycosyl
site
one
option
block
merscov
infect
take
advantag
highli
glycosyl
natur
spike
protein
use
lectin
order
inhibit
merscov
entri
thu
viru
propag
griffithsin
grft
amino
acid
long
lectin
isol
red
marin
alga
griffithsia
sp
griffithsin
shown
antivir
activ
within
picomolar
rang
mori
et
al
cell
treat
increas
concentr
griffithsin
mgml
mgml
lectin
b
h
incub
supernat
replac
medium
without
griffithsin
cell
incub
c
h
b
cell
left
treat
griffithsin
h
h
cell
viabil
measur
use
luminescencebas
atp
quantit
assay
result
express
averag
cell
viabil
mgml
control
error
bar
repres
sd
averag
three
independ
experi
data
statist
analyz
use
oneway
anova
test
use
twotail
student
ttest
b
follow
convent
pvalu
signific
signific
ns
p
c
doserespons
analysi
griffithsin
merscov
infect
immunofluoresc
assay
merscovinfect
cell
presenc
increas
concentr
griffithsin
cell
infect
merscov
strain
moi
presenc
increas
amount
griffithsin
h
c
pb
use
nontreat
control
condit
cell
wash
pb
inoculum
replac
cell
growth
medium
cell
incub
c
co
addit
h
cell
fix
immunolabel
merscov
stain
nuclei
dapi
ni
non
infect
control
quantif
merscovposit
cell
presenc
increas
concentr
griffithsin
condit
five
object
field
randomli
acquir
analyz
total
number
character
griffithsin
structur
demonstr
domainswap
homodim
three
carbohydr
bind
domain
monom
bind
termin
mannos
residu
link
hiv
envelop
protein
nglycan
zi
et
al
griffithsin
also
identifi
potent
inhibitor
hepat
c
viru
hcv
sarscov
infect
vitro
vivo
minim
toxic
meuleman
et
al
okeef
et
al
therefor
evalu
antimerscov
activ
griffithsin
atcc
nakabayashi
et
al
atcc
atcc
cell
grown
c
co
dmem
corn
supplement
fetal
bovin
serum
thermofish
mm
hepe
corn
iuml
penicillin
mgml
streptomycin
corn
baric
unc
chapel
hill
bart
haagman
utrecht
univers
viru
propag
cell
viral
titrat
perform
use
tcid
assay
experi
involv
authent
merscov
perform
biosafeti
level
facil
anim
health
diagnost
center
cornel
univers
mannonanosedi
nacetyldglucosamin
glycan
purchas
sigma
aldrich
celltiterglo
luminesc
cell
viabil
assay
reagent
luciferas
assay
kit
purchas
promega
cell
seed
plate
incub
h
c
co
incub
cell
treat
increas
concentr
griffithsin
pb
mgml
rang
use
subsequ
experi
treat
cell
incub
c
co
h
medium
replac
fresh
growth
medium
without
griffithsin
cell
incub
anoth
h
c
co
test
effect
griffithsin
longer
incub
time
cell
left
treat
either
mgml
griffithsin
h
h
cell
lyse
viabil
assay
use
celltiterglo
kit
accord
manufactur
guidelin
luminesc
rel
luminesc
unit
rlu
read
perform
use
glomax
luminomet
promega
percent
cell
viabil
calcul
follow
equat
assay
carri
use
triplic
well
data
correspond
averag
three
independ
experi
cell
seed
well
chamber
slide
ibidi
incub
c
co
h
increas
concentr
griffithsin
mgml
ad
merscov
strain
viral
inoculum
use
infect
cell
multipl
infect
moi
noninfect
cell
pbstreat
viru
inoculum
use
neg
control
infect
cell
incub
c
co
h
inoculum
remov
follow
pb
wash
remov
unbound
virion
addit
cell
cultur
medium
infect
left
proceed
c
co
addit
h
well
chamber
slide
process
immunofluoresc
assay
describ
immunofluoresc
microscopi
assay
cell
seed
plate
well
incub
c
co
h
cell
infect
viru
inoculum
untreat
treat
mgml
griffithsin
infect
cell
incub
c
co
h
inoculum
remov
follow
pb
wash
remov
unbound
virion
addit
cell
cultur
medium
contain
mgml
griffithsin
cell
left
incub
c
co
h
h
post
infect
time
point
cell
cultur
supernat
harvest
store
c
cell
titrat
perform
use
tcid
assay
cell
result
express
log
tcid
ml
repres
averag
two
independ
experi
particl
pseudotyp
either
merscov
envelop
protein
merspp
genotyp
hcv
envelop
protein
hcvpp
g
envelop
glycoprotein
vesicular
stomat
viru
vsvgpp
produc
previous
describ
belouzard
et
al
op
de
beeck
et
al
pseudotyp
virion
use
inocul
cell
plate
h
presenc
griffithsin
inoculum
remov
cell
incub
cultur
medium
h
cell
lyse
luciferas
activ
detect
use
luciferas
assay
kit
promega
light
emiss
measur
use
tristar
lb
luminomet
berthold
technolog
competit
experi
griffithsin
preincub
differ
concentr
h
c
ad
merspp
h
inocul
step
cell
inoculum
remov
luciferas
activ
quantifi
h
post
inocul
describ
cell
seed
well
chamber
slide
ibidi
incub
c
co
h
viru
infect
divid
four
step
inocul
attach
viru
h
c
pb
wash
remov
unbound
viru
follow
bind
bound
viru
h
c
intern
h
c
infect
h
c
condit
cell
infect
merscov
strain
moi
griffithsin
mgml
ad
differ
step
viru
entri
experiment
condit
griffithsin
present
step
condit
b
griffithsin
present
initi
attach
viru
cell
condit
c
griffithsin
ad
cell
dapi
nuclei
stain
sposit
cell
infect
cell
result
express
percentag
infect
cell
error
bar
repres
sd
averag
three
independ
experi
data
statist
analyz
use
oneway
anova
test
follow
convent
pvalu
signific
highli
signific
p
bind
step
condit
griffithsin
present
intern
final
condit
e
griffithsin
present
initi
attach
bind
intern
step
infect
merscov
infect
left
proceed
h
c
well
chamber
slide
process
immunofluoresc
assay
describ
immunofluoresc
microscopi
assay
immunofluoresc
perform
previous
describ
millet
whittak
quantif
condit
field
randomli
acquir
field
total
number
cell
dapi
stain
number
infect
cell
spike
label
count
use
automat
cell
count
softwar
imari
result
quantif
express
percentinfect
cell
experi
perform
use
duplic
well
data
correspond
averag
three
independ
experi
purifi
solubl
merscov
spike
protein
incub
triton
pb
presenc
absenc
mg
ml
griffithsin
h
c
follow
addit
polyclon
antigriffithsin
antibodi
h
incub
proteinantibodi
complex
precipit
protein
sepharos
bead
preincub
bsa
avoid
nonspecif
bind
protein
separ
sdspage
transfer
nitrocellulos
membran
amersham
spike
protein
immunodetect
antibodi
thermofish
analysi
experiment
data
calcul
standard
deviat
sd
standard
error
mean
sem
graph
plot
perform
use
graphpad
prism
statist
analys
perform
use
oneway
anova
test
doserespons
cell
viabil
viral
infect
twotail
student
ttest
viral
titer
assay
competit
bind
assay
pvalu
signific
follow
convent
use
signific
ns
p
signific
p
highli
signific
p
highli
signific
p
assess
effect
griffithsin
cell
viabil
test
potenti
cytotox
treat
cell
rang
griffithsin
concentr
use
subsequ
experi
mgml
fig
mgml
longer
treatment
exposur
time
fig
griffithsin
decreas
cell
viabil
dose
time
test
result
agreement
previou
investig
nixon
et
al
determin
inhibitori
activ
griffithsin
merscov
infect
carri
doserespons
infect
experi
three
differ
cell
line
fig
cell
infect
strain
merscov
moi
presenc
increas
concentr
griffithsin
mgml
infect
cell
fix
earli
infect
time
point
h
assay
immunofluoresc
microscopi
analysi
fig
follow
quantif
percentag
infect
cell
concentr
fig
griffithsin
significantli
decreas
infect
merscov
clear
dosedepend
inhibitori
effect
cell
line
test
fig
even
dilut
concentr
mgml
test
inhibitori
activ
griffithsin
merscov
infect
signific
minim
drop
infect
cell
maxim
drop
cell
compar
condit
without
lectin
mgml
griffithsin
inhibit
viral
infect
cell
line
test
perform
assay
use
high
moi
short
infect
time
result
show
strong
inhibitori
activ
griffithsin
earli
step
merscov
viral
cycl
investig
effect
griffithsin
merscov
viru
titer
fig
cell
infect
merscov
presenc
mgml
griffithsin
h
h
post
infect
cell
supernat
harvest
analyz
viru
titer
perform
tcid
assay
fig
cell
line
griffithsin
significantli
decreas
viru
titer
h
fig
effect
griffithsin
merscov
viru
titer
cell
seed
well
plate
infect
merscov
presenc
mgml
griffithsin
h
incub
inoculum
remov
cell
incub
presenc
absenc
mgml
griffithsin
h
h
post
infect
supernat
harvest
tcid
assay
perform
collect
supernat
use
cell
result
express
averag
log
tcid
ml
error
bar
repres
sd
averag
two
independ
experi
data
statist
analyz
use
twotail
student
ttest
follow
convent
pvalu
signific
signific
p
time
point
confirm
inhibitori
role
lectin
merscov
infect
griffithsin
shown
inhibit
cellular
entri
numer
virus
includ
sarscov
confirm
result
obtain
merscov
determin
activ
molecul
entri
mediat
merscov
spike
protein
merscov
pseudotyp
virion
merspp
produc
use
infect
cell
dosedepend
inhibit
merspp
infect
observ
presenc
griffithsin
fig
suggest
compound
abl
inhibit
merscov
entri
expect
griffithsin
also
abl
inhibit
hcvpp
infect
effect
vsvgpp
infect
previous
describ
meuleman
et
al
griffithsin
known
interact
nlink
high
mannos
oligosaccharid
antivir
effect
compound
shown
due
interact
griffithsin
mannos
link
viral
envelop
protein
moulaei
et
al
confirm
inhibit
observ
specif
griffithsin
activ
competit
assay
use
nlink
high
mannos
oligosaccharid
mannonosedi
nacetyldglucosamin
glycan
perform
shown
fig
incub
merspp
griffithsin
preincub
first
glycan
significantli
restor
infect
pseudotyp
particl
suggest
griffithsin
interact
mannos
merscov
envelop
impair
function
entri
confirm
griffithsin
interact
merscov
spike
protein
perform
coimmunoprecipit
assay
solubl
merscov
spike
protein
incub
presenc
absenc
griffithsin
presenc
spike
protein
complex
griffithsin
analyz
western
blot
immunoprecipit
polyclon
antigriffithsin
antibodi
fig
western
blot
analysi
reveal
spike
protein
could
coimmunoprecipit
presenc
griffithsin
better
defin
stage
viru
life
cycl
griffithsin
act
perform
infect
assay
use
authent
merscov
griffithsin
present
differ
time
viral
entri
step
fig
experi
viral
entri
step
divid
attach
c
bind
c
intern
c
control
condit
griffithsin
either
present
entri
step
present
entri
step
e
latter
condit
griffithsin
signific
inhibitori
effect
infect
compar
control
condit
result
recapitul
well
doserespons
result
fig
c
note
howev
infect
condit
lower
h
c
ad
merspp
infect
intracellular
firefli
luciferas
signal
measur
describ
experi
perform
three
time
duplic
triplic
error
bar
repres
sem
data
statist
analyz
use
twotail
student
ttest
compar
result
nontreat
condit
follow
convent
pvalu
signific
signific
ns
signific
p
highli
signific
p
highli
signific
p
c
solubl
merscov
spike
protein
incub
presenc
absenc
mgml
griffithsin
griffithsin
immunoprecipit
merscov
spike
protein
detect
western
blot
observ
nontreat
control
dose
respons
experi
attribut
drop
differ
infect
assay
use
shorter
inoculum
contact
time
multipl
pb
wash
condit
b
griffithsin
present
first
attach
step
signific
decreas
infect
measur
fig
signific
inhibit
observ
condit
c
griffithsin
present
later
step
entri
bind
without
inoculum
intern
respect
taken
togeth
data
reveal
griffithsin
act
earli
stage
viru
entri
probabl
directli
interact
glycosyl
part
merscov
spike
protein
inhibit
bind
function
merscov
emerg
saudi
arabia
caus
sever
pneumonia
less
year
sarscov
emerg
china
case
merscov
persontoperson
transmiss
second
step
viral
inoculum
remov
cell
wash
three
time
cold
pb
kept
c
h
enabl
bind
viru
cell
surfac
presenc
c
e
absenc
b
mgml
griffithsin
third
step
cell
place
c
h
allow
intern
virion
occur
presenc
e
absenc
b
c
mgml
griffithsin
infect
left
proceed
last
h
step
c
absenc
griffithsin
b
immunofluoresc
assay
merscovinfect
cell
griffithsin
present
differ
stage
infect
cell
infect
treat
describ
fix
immunolabel
analyz
describ
previous
fig
c
quantif
merscovposit
cell
condit
test
cell
analyz
describ
fig
result
express
percentag
infect
cell
error
bar
repres
sd
averag
three
independ
experi
data
statist
analyz
use
twotail
student
ttest
compar
result
nontreat
condit
follow
convent
pvalu
signific
signific
ns
p
highli
signific
p
occur
howev
transmiss
sustain
basic
reproduct
number
merscov
zoonot
viru
camel
bat
like
reservoir
sarscovlik
virus
isol
bat
like
bat
reservoir
sarscov
ancestor
consid
increas
number
divers
coronavirus
identifiedisol
bat
proven
propens
coronavirus
cross
speci
barrier
infect
new
host
like
new
coronavirus
caus
sever
diseas
human
may
emerg
futur
current
drug
proven
efficaci
treat
merscov
coronaviru
infect
treatment
limit
support
care
respiratori
circulatori
function
prevent
care
protect
renal
hepat
neurolog
function
prevent
secondari
infect
consequ
new
therapi
urgent
need
viru
featur
conserv
among
coronaviru
famili
attract
target
develop
antivir
therapi
fight
current
futur
emerg
coronaviru
infect
coronaviru
spike
protein
main
determin
viru
entri
tropism
belouzard
et
al
glycoprotein
variabl
sequenc
length
share
organ
two
domain
domain
respons
receptor
bind
attach
viru
host
cell
surfac
wherea
contain
fusion
machineri
common
featur
coronaviru
spike
protein
high
glycosyl
potenti
glycosyl
site
coronaviru
spike
protein
exclus
nglycosyl
therefor
carbohydratebind
protein
lectin
attract
anticoronaviru
candid
griffithsin
lectin
isol
red
marin
alga
griffithsia
sp
shown
inhibit
hiv
hcv
sarscov
within
nanomolar
rang
demonstr
griffithsin
minim
effect
cell
viabil
potent
inhibitor
merscov
infect
product
vitro
use
particl
pseudotyp
merscov
spike
protein
shown
griffithsin
act
merscov
entri
among
viral
protein
anchor
merscov
envelop
addit
spike
protein
protein
harbor
potenti
nglycosyl
site
short
ntermin
domain
mhv
shown
protein
may
addit
target
lectin
enhanc
antivir
effect
griffithsin
inhibit
merscov
pseudotypedparticl
extent
merscov
infect
suggest
spike
protein
main
target
griffithsin
antivir
effect
inde
result
indic
direct
interact
griffithsin
merscov
spike
protein
hiv
griffithsin
bind
termin
mannos
nglycan
bind
slightli
interfer
bind
like
prevent
conform
rearrang
requir
entri
mori
et
al
sarscov
shown
griffithsin
affect
bind
suggest
griffithsin
act
postbind
step
entri
plant
lectin
galanthu
nivali
agglutinin
gna
hippeasttrum
hybrid
lectin
hha
urtica
dioica
agglutinin
uda
also
shown
prevent
mhv
entri
postbind
step
probabl
interf
conform
rearrang
spike
protein
drive
fusion
viral
envelop
host
cell
membran
van
der
meer
et
al
merscov
result
show
griffithsin
inhibit
infect
differ
mechan
fact
found
griffithsin
interfer
infect
earli
attach
step
like
prevent
interact
spike
abl
prevent
merscov
infect
ad
postbind
step
inde
similar
mechan
receptor
bind
interfer
alreadi
observ
hcv
meuleman
et
al
crystal
structur
merscov
receptor
bind
domain
rbd
residu
resolv
combin
absenc
merscov
rbd
contain
core
domain
accessori
subdomain
lie
edg
core
structur
chen
et
al
lu
et
al
subdomain
contain
nlink
glycan
core
domain
accessori
domain
contribut
sugar
moieti
virusreceptor
interact
unknown
one
imagin
involv
one
nglycan
receptor
bind
could
impair
griffithsin
conclus
griffithsin
low
cytotox
like
interact
coronaviru
spike
protein
highli
glycosyl
natur
abl
hamper
coronaviru
spike
protein
function
griffithsin
consid
interest
drug
candid
develop
treatment
andor
prevent
current
also
futur
emerg
coronaviru
infect
